The promoter -1031(T/C) polymorphism in tumor necrosis factor-alpha associated with polycystic ovary syndrome

[1] Futterweit W(1999)Polycystic ovary syndrome: clinical perspectives and management Obestet Gynecol Surv 54 403-413

[2] Carmina E(1999)Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women J Clin Endocrinol Metab 84 1897-1899

[3] Lobo RA(2004)Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil Steril 81 19-25

[4] Lergo RS(1999)Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women J Clan Endocrinal Metal 84 165-169

[5] Kunselman AR(2005)Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups Fertil Steril 83 1717-1723

[6] Dodson WC(2006)Diagnosis and management of polycystic ovary syndrome: a practical guide Drug 66 903-912

[7] Dunaif A(2004)Polycystic ovary syndrome: diagnosis and management Clin Med Res 2 13-27

[8] Chang WY(1995)IL-1 beta, TNF-alpha and IL-2 in peritoneal fluid and macrophage conditioned media of women with endometriosis Am J Rerprod Immunol 34 381-385

[9] Knochenhauer ES(2002)Peritoneal fluid-mediates enhancement of eutopic and ectopic endometrial cell proliferation in dependent on tumor necrosis factor-alpha in women with endometriosis Fertil Steril 78 727-732

[10] Bartolucci AA(1995)TNF immunity and inflammatory disease: lessions of the past decade J Invest Med 43 227-235

[1] Futterweit W(1999)Polycystic ovary syndrome: clinical perspectives and management Obestet Gynecol Surv 54 403-413

[2] Carmina E(1999)Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women J Clin Endocrinol Metab 84 1897-1899

[3] Lobo RA(2004)Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil Steril 81 19-25

[4] Lergo RS(1999)Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women J Clan Endocrinal Metal 84 165-169

[5] Kunselman AR(2005)Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups Fertil Steril 83 1717-1723

[6] Dodson WC(2006)Diagnosis and management of polycystic ovary syndrome: a practical guide Drug 66 903-912

[7] Dunaif A(2004)Polycystic ovary syndrome: diagnosis and management Clin Med Res 2 13-27

[8] Chang WY(1995)IL-1 beta, TNF-alpha and IL-2 in peritoneal fluid and macrophage conditioned media of women with endometriosis Am J Rerprod Immunol 34 381-385

[9] Knochenhauer ES(2002)Peritoneal fluid-mediates enhancement of eutopic and ectopic endometrial cell proliferation in dependent on tumor necrosis factor-alpha in women with endometriosis Fertil Steril 78 727-732

[10] Bartolucci AA(1995)TNF immunity and inflammatory disease: lessions of the past decade J Invest Med 43 227-235